Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate clinical trial (NCT00847613). Contact the study team or your healthcare provider for specific answers.

Question 2

How does CP-690,550 compare to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate clinical trial (NCT00847613). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the study visits involve and how often will I need to come in?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate clinical trial (NCT00847613). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate clinical trial (NCT00847613). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I don't respond to the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate clinical trial (NCT00847613). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate clinical trial (NCT00847613). Contact the study team or your healthcare provider for specific answers.

What this study is about